
  
    
      
        Introduction_NNP
        Since_IN the_DT early_JJ 1990_CD s_VBZ ,_, spiral_NN computed_JJ tomography_NN (_( CT_NNP )_)
        scanners_NNS have_VBP permitted_VBN assessment_NN of_IN the_DT entire_JJ pulmonary_JJ
        parenchyma_NN in_IN a_DT very_RB short_JJ period_NN of_IN time_NN [_NN 1_CD ,_, 2_CD ,_, 3_CD ]_NN ._. In_IN
        patients_NNS with_IN acute_JJ lung_NN injury_NN (_( ALI_NNP )_) injection_NN of_IN contrast_NN
        material_NN is_VBZ considered_VBN useful_JJ for_IN differentiating_VBG
        consolidated_JJ lung_NN parenchyma_NN from_IN pleural_NN effusion_NN and_CC for_IN
        diagnosing_VBG lung_NN abscess_NNS ._. It_PRP is_VBZ also_RB required_VBN for_IN diagnosis_NN
        of_IN pulmonary_JJ embolism_NN ._. As_IN a_DT consequence_NN ,_, injection_NN of_IN
        contrast_NN material_NN is_VBZ routinely_RB performed_VBN in_IN critically_RB ill_JJ
        patients_NNS undergoing_VBG a_DT thoracic_JJ CT_NNP scan_VB [_NN 4_CD ,_, 5_CD ]_NN ._.
        In_IN the_DT presence_NN of_IN alterations_NNS in_IN the_DT blood-brain_JJ
        barrier_NN ,_, injection_NN of_IN contrast_NN material_NN increases_NNS brain_NN
        oedema_NN [_NN 6_CD ,_, 7_CD ,_, 8_CD ,_, 9_CD ]_NN ._. This_DT is_VBZ due_JJ to_TO the_DT direct_JJ toxic_JJ
        effects_NNS of_IN the_DT contrast_NN material_NN on_IN nerve_NN cells_NNS [_NN 10_CD ]_NN ,_,
        which_WDT result_VBP from_IN its_PRP$ osmotic_JJ effect_NN after_IN intracellular_NN
        penetration_NN ._. Similarly_RB ,_, in_IN ALI_NNP breakdown_NN of_IN the_DT
        constituents_NNS of_IN the_DT alveolar-capillary_JJ barrier_NN (_( pulmonary_JJ
        epithelium_NN or_CC capillary_JJ endothelium_NN )_) causes_NNS an_DT increase_NN in_IN
        lung_NN permeability_NN ,_, which_WDT is_VBZ accompanied_VBN by_IN interstitial_NN and_CC
        alveolar_NN accumulation_NN of_IN water_NN and_CC proteins_NNS [_NN 11_CD ]_NN ._.
        Alteration_NNP in_IN the_DT alveolar-capillary_JJ barrier_NN could_MD also_RB
        promote_VB leakage_NN of_IN contrast_NN material_NN into_IN the_DT interstitial_NN
        and_CC alveolar_NN spaces_NNS ,_, with_IN a_DT consequent_JJ increase_NN in_IN
        extravascular_NN lung_NN water_NN ._. Using_VBG CT_NNP ,_, the_DT latter_NN may_MD be_VB
        measured_VBN as_IN an_DT increase_NN in_IN lung_NN tissue_NN ._. However_RB ,_,
        administration_NN of_IN contrast_NN material_NN creates_VBZ a_DT density_NN
        artifact_NN that_WDT may_MD lead_VB to_TO an_DT overestimation_NN of_IN lung_NN tissue_NN ._.
        The_DT aim_NN of_IN the_DT present_JJ study_NN was_VBD to_TO evaluate_VB the_DT effects_NNS of_IN
        intravenous_JJ injection_NN of_IN contrast_NN material_NN on_IN CT_NNP
        measurement_NN of_IN volumes_NNS of_IN gas_NN and_CC lung_NN tissue_NN in_IN patients_NNS
        with_IN ALI_NNP ,_, and_CC to_TO test_VB the_DT hypothesis_NNS that_WDT administration_NN of_IN
        contrast_NN material_NN increases_NNS extravascular_NN lung_NN water_NN ._. In_IN
        addition_NN ,_, in_IN order_NN to_TO estimate_VB the_DT range_NN of_IN error_NN in_IN
        determining_VBG lung_NN tissue_NN that_IN results_NNS from_IN administration_NN of_IN
        contrast_NN material_NN ,_, a_NNP '_POS lung_NN phantom_JJ '_POS was_VBD filled_VBN with_IN known_VBN
        volumes_NNS of_IN water_NN containing_VBG increasing_VBG concentrations_NNS of_IN
        contrast_NN material_NN and_CC was_VBD scanned_JJ to_TO compare_VB the_DT calculated_VBN
        increases_NNS in_IN volume_NN of_IN water_NN with_IN the_DT actual_JJ instilled_JJ
        volume_NN ._.
      
      
        Materials_NNS and_CC method_NN
        
          Patients_NNS
          Fourteen_CD patients_NNS hospitalized_VBN in_IN the_DT Surgical_NNP
          Intensive_NNP Care_NNP Unit_NNP of_IN La_NNP Pitié-_NNP Salpétrière_NNP for_IN ALI_NNP were_VBD
          prospectively_RB studied_VBN [_NN 12_CD ]_NN ._. Inclusion_NNP criteria_NNS were_VBD as_IN
          follows_VBZ :_: a_DT ratio_NN of_IN arterial_NN oxygen_NN tension_NN to_TO fractional_JJ
          inspired_VBN oxygen_NN of_IN less_JJR than_IN 300_CD mmHg_NN at_IN zero_CD
          end-expiratory_JJ pressure_NN ;_: bilateral_JJ hyper-densities_JJ on_IN a_DT
          bedside_NN chest_NN radiogram_NN ;_: and_CC pulmonary_JJ capillary_JJ wedge_NN
          pressure_NN below_IN 18_CD mmHg_NN and_CC /_NN or_CC left_VBD ventricular_NN ejection_NN
          fraction_NN greater_JJR than_IN 50_CD %_NN ,_, as_IN estimated_VBN by_IN
          transoesophageal_NN echocardiography_NN ._. Informed_NNP consent_NN was_VBD
          obtained_VBN from_IN the_DT patients_NNS '_POS next_JJ of_IN kin_NN ._. In_IN each_DT patient_NN ,_,
          a_DT thoracic_JJ CT_NNP scan_VB with_IN injection_NN of_IN contrast_NN material_NN
          was_VBD indicated_VBN clinically_RB for_IN diagnosing_VBG lung_NN abscess_NNS ,_,
          pulmonary_JJ embolism_NN or_CC pleural_NN effusion_NN ._.
        
        
          Spiral_NNP thoracic_JJ computed_JJ tomography_NN scan_VB :_: technical_JJ
          characteristics_NNS
          Each_DT patient_NN was_VBD transported_VBN to_TO the_DT Department_NNP of_IN
          Radiology_NNP (_( Thoracic_NNP Division_NNP )_) by_IN two_CD experienced_VBN
          physicians_NNS ._. Patients_NNS were_VBD sedated_JJ and_CC paralyzed_VBN with_IN a_DT
          continuous_JJ intravenous_JJ infusion_NN of_IN 5_CD g_SYM /_NN kg_NN per_IN hour_NN
          fentanyl_NN ,_, 0_CD ._. 1_CD mg_NN /_NN kg_NN per_IN hour_NN midazolam_NN and_CC 0_CD ._. 05_CD mg_NN /_NN kg_NN per_IN
          hour_NN vecuronium_NN ._. Mechanical_NNP ventilation_NN was_VBD provided_VBN
          using_VBG an_DT Osiris_NNP ventilator_NN (_( Taema_NNP ,_, Antony_NNP ,_, France_NNP )_) ,_, which_WDT
          was_VBD specifically_RB designed_VBN for_IN delivering_VBG 100_CD %_NN oxygen_NN
          during_IN transportation_NN of_IN critically_RB ill_JJ patients_NNS ._.
          Electrocardiography_NNP ,_, pulse_NN oxymetry_NN and_CC systemic_JJ arterial_NN
          pressure_NN were_VBD monitored_VBN continuously_RB using_VBG a_DT Propaq_NNP 104_CD
          EL_NNP monitor_VB (_( Protocol_NNP System_NNP ,_, North_NNP Chicago_NNP ,_, IL_NNP ,_, USA_NNP )_) ._.
          Spiral_NNP lung_NN scanning_VBG was_VBD performed_VBN at_IN end-expiration_JJ
          from_IN the_DT apex_NN to_TO the_DT diaphragm_NN using_VBG a_DT Tomoscan_NNP SR_NNP 7000_CD
          (_( Philips_NNP ,_, Eindhoven_NNP ,_, The_DT Netherlands_NNP )_) ._. Disconnection_NNP from_IN
          the_DT ventilator_NN and_CC 15_CD s_VBZ apnoea_NN were_VBD necessary_JJ to_TO obtain_VB
          the_DT CT_NNP sections_NNS ,_, which_WDT resulted_VBD in_IN a_DT transient_JJ
          desaturation_NN in_IN most_JJS patients_NNS ,_, the_DT lowest_JJS oxygen_NN
          saturation_NN measured_VBD being_VBG 87_CD %_NN ._. All_DT images_NNS were_VBD observed_VBN
          and_CC photographed_VBN at_IN a_DT window_NN width_NN of_IN 1600_CD Hounsfield_NNP
          units_NNS (_( HU_NNP )_) and_CC a_DT level_NN of_IN -_: 700_CD HU_NNP ._. The_DT exposures_NNS were_VBD
          taken_VBN at_IN 120_CD kV_NN and_CC 250_CD mA_NN ._. The_DT value_NN of_IN the_DT pitch_NN was_VBD 1_CD ._.
          In_IN the_DT present_JJ study_NN ,_, each_DT voxel_NN had_VBD a_DT volume_NN of_IN 1_CD ._. 7_CD mm_NN
          3_CD ._. As_IN previously_RB described_VBD [_NN 2_CD ,_, 3_CD ,_, 13_CD ,_, 14_CD ]_NN ,_, we_PRP evaluated_VBD
          contiguous_JJ axial_NN CT_NNP sections_NNS 10_CD mm_NN thick_JJ ,_, which_WDT were_VBD
          reconstructed_VBN from_IN the_DT volumetric_JJ data_NN ._. On_IN each_DT CT_NNP
          section_NN ,_, right_NN and_CC left_VBD lung_NN parenchyma_NN were_VBD delineated_JJ
          using_VBG the_DT roller_NN ball_NN of_IN the_DT computer_NN ._. The_DT
          reproducibility_NN of_IN manual_JJ delineation_NN was_VBD excellent_JJ ,_, with_IN
          determinations_NNS of_IN the_DT overall_JJ lung_NN volume_NN by_IN three_CD
          different_JJ operators_NNS showing_VBG a_DT maximal_NN difference_NN of_IN 25_CD
          ml_NN ._. The_DT respective_JJ volumes_NNS of_IN gas_NN and_CC lung_NN tissue_NN ,_, and_CC
          the_DT distribution_NN of_IN lung_NN aeration_NN were_VBD compared_VBN before_IN
          and_CC after_IN injection_NN of_IN contrast_NN material_NN using_VBG the_DT
          Lungview_NNP ®_NN (_( Institut_NNP National_NNP des_NNP Télécommunications_NNP ,_,
          Evry_NNP ,_, France_NNP )_) ,_, as_IN was_VBD previously_RB described_VBN [_NN 2_CD ,_, 3_CD ,_, 4_CD ,_,
          15_CD ]_NN ._.
          Two_CD groups_NNS of_IN patients_NNS were_VBD studied_VBN ;_: in_IN group_NN 1_CD (_( 
          n_NN =_SYM 7_CD )_) CT_NNP sections_NNS were_VBD acquired_VBN
          before_IN and_CC 30_CD s_VBZ after_IN injection_NN of_IN contrast_NN material_NN ,_, and_CC
          in_IN group_NN 2_CD (_( 
          n_NN =_SYM 7_CD )_) the_DT CT_NNP sections_NNS were_VBD
          obtained_VBN before_IN and_CC 15_CD min_NN after_IN injection_NN of_IN contrast_NN
          material_NN ._. In_IN both_DT groups_NNS ,_, a_DT volume_NN of_IN 80_CD ml_NN of_IN contrast_NN
          material_NN (_( iobitridol_NN ;_: Xenetix_NNP 350_CD ,_, Guerbet_NNP ,_, Roissy_NNP ,_,
          France_NNP )_) was_VBD automatically_RB injected_VBN into_IN the_DT superior_JJ vena_NN
          cava_NN at_IN a_DT constant_JJ flow_NN of_IN 4_CD ml_NN /_NN s_VBZ ._. In_IN one_CD patient_NN ,_, CT_NNP
          sections_NNS acquired_VBD 30_CD s_VBZ after_IN the_DT injection_NN of_IN contrast_NN
          material_NN were_VBD repeated_VBN 15_CD min_NN later_RB ._.
        
        
          Computed_NNP tomography_NN measurement_NN of_IN lung_NN volumes_NNS and_CC
          blood_NN density_NN
          
            Apparent_NNP lung_NN volumes_NNS of_IN gas_NN and_CC tissue_NN
            CT_NNP scans_VBZ obtained_VBN before_IN and_CC after_IN injection_NN of_IN
            contrast_NN material_NN were_VBD analyzed_VBN using_VBG specially_RB
            designed_VBN software_NN (_( Lungview_NNP ®_NN )_) ,_, which_WDT is_VBZ based_VBN on_IN the_DT
            tight_JJ correlations_NNS that_WDT exist_VBP between_IN radiological_JJ and_CC
            physical_JJ densities_NNS [_NN 16_CD ]_NN ._.
            Before_IN and_CC after_IN injection_NN of_IN contrast_NN material_NN ,_, the_DT
            analysis_NN was_VBD performed_VBN according_VBG to_TO the_DT following_VBG
            principles_NNS ._. The_DT CT_NNP number_NN characterizing_VBG each_DT
            individual_JJ voxel_NN is_VBZ expressed_VBN in_IN HU_NNP and_CC is_VBZ defined_VBN as_IN
            the_DT attenuation_NN coefficient_NN of_IN the_DT radiogram_NN by_IN the_DT
            material_NN being_VBG studied_VBN minus_CC the_DT attenuation_NN
            coefficient_NN of_IN water_NN divided_VBN by_IN the_DT attenuation_NN
            coefficient_NN of_IN water_NN ._. By_IN convention_NN ,_, the_DT CT_NNP number_NN of_IN
            water_NN is_VBZ 0_CD (_( HU_NNP )_) ._. The_DT CT_NNP number_NN is_VBZ scaled_VBN by_IN a_DT factor_NN
            1000_CD ,_, the_DT CT_NNP number_NN of_IN gas_NN being_VBG -_: 1000_CD HU_NNP ._. A_DT lung_NN area_NN
            characterized_VBN by_IN a_DT mean_NN CT_NNP number_NN of_IN -_: 500_CD HU_NNP is_VBZ
            considered_VBN to_TO be_VB composed_VBN of_IN 50_CD %_NN gas_NN and_CC 50_CD %_NN tissue_NN ._. A_DT
            lung_NN area_NN characterized_VBN by_IN a_DT mean_NN CT_NNP number_NN of_IN -_: 200_CD HU_NNP
            is_VBZ considered_VBN to_TO be_VB composed_VBN of_IN 20_CD %_NN gas_NN and_CC 80_CD %_NN tissue_NN ._.
            Using_VBG this_DT analysis_NN ,_, it_PRP was_VBD possible_JJ to_TO compute_VB the_DT
            volume_NN of_IN gas_NN and_CC tissue_NN present_JJ in_IN the_DT lungs_NNS ._.
            In_IN the_DT first_JJ step_NN ,_, the_DT distribution_NN of_IN CT_NNP numbers_NNS
            was_VBD measured_VBN on_IN each_DT CT_NNP section_NN for_IN 256_CD compartments_NNS
            between_IN -_: 1200_CD HU_NNP and_CC +_NN 200_CD HU_NNP ,_, examining_VBG an_DT interval_NN of_IN
            5_CD ._. 47_CD HU_NNP per_IN compartment_NN ._. For_IN each_DT compartment_NN of_IN a_DT
            known_VBN number_NN of_IN voxels_NNS ,_, the_DT total_JJ volume_NN and_CC the_DT volume_NN
            of_IN gas_NN and_CC lung_NN tissue_NN were_VBD computed_JJ using_VBG the_DT
            following_NN equations_NNS (_( in_IN which_WDT '_POS CT_NNP '_POS is_VBZ the_DT mean_NN CT_NNP
            number_NN of_IN the_DT compartment_NN analyzed_VBD )_) :_:
            Volume_NN of_IN the_DT voxel_NN =_SYM (_( size_NN of_IN the_DT pixel_NN )_) 2_CD ×_NN section_NN
            thickness_NN (_( 1_LS )_)
            Total_JJ volume_NN =_SYM number_NN of_IN voxels_NNS ×_NN volume_NN of_IN the_DT
            voxel_NN (_( 2_LS )_)
            Apparent_NNP volume_NN of_IN gas_NN =_SYM (_( -_: CT_NNP /_NN 1000_CD )_) ×_NN total_JJ volume_NN ,_,
            if_IN the_DT compartment_NN considered_VBN has_VBZ a_DT CT_NNP number_NN below_IN 0_CD
            (_( volume_NN of_IN gas_NN =_SYM 0_CD if_IN the_DT compartment_NN considered_VBN has_VBZ a_DT
            CT_NNP number_NN above_IN 0_CD )_) (_( 3_LS )_)
            Apparent_NNP volume_NN of_IN tissue_NN =_SYM (_( [_NN 1_CD +_NN CT_NNP ]_NN /_NN 1000_CD )_) ×_NN total_JJ
            volume_NN ,_, if_IN the_DT compartment_NN considered_VBN has_VBZ a_DT CT_NNP number_NN
            below_IN 0_CD (_( 4_LS )_)
            or_CC ,_, volume_NN of_IN tissue_NN =_SYM number_NN of_IN voxels_NNS ×_NN volume_NN of_IN
            the_DT voxel_NN ,_, if_IN the_DT compartment_NN considered_VBN has_VBZ a_DT CT_NNP
            number_NN above_IN 0_CD (_( 4_CD '_'' )_)
            In_IN a_DT second_JJ step_NN ,_, the_DT volumes_NNS of_IN gas_NN and_CC lung_NN tissue_NN
            of_IN each_DT region_NN of_IN interest_NN were_VBD calculated_VBN by_IN adding_VBG
            the_DT values_NNS of_IN all_DT of_IN the_DT compartments_NNS present_JJ within_IN
            the_DT region_NN of_IN interest_NN considered_VBN ._. In_IN a_DT third_JJ step_NN ,_, the_DT
            volumes_NNS of_IN gas_NN and_CC lung_NN tissue_NN of_IN both_DT lungs_NNS were_VBD
            calculated_VBN by_IN adding_VBG the_DT volumes_NNS of_IN all_DT lung_NN regions_NNS
            (_( right_JJ lung_NN +_NN left_VBD lung_NN )_) ._. The_DT total_JJ lung_NN volume_NN at_IN
            end-expiration_JJ was_VBD defined_VBN as_IN the_DT sum_NN of_IN gas_NN and_CC tissue_NN
            volumes_NNS ._. The_DT overall_JJ volume_NN of_IN gas_NN present_JJ at_IN
            end-expiration_JJ in_IN both_DT lungs_NNS was_VBD defined_VBN as_IN functional_JJ
            residual_JJ capacity_NN ._.
            The_DT distribution_NN of_IN lung_NN tissue_NN along_IN the_DT
            cephalocaudal_NN axis_NNS was_VBD determined_VBN in_IN patients_NNS by_IN taking_VBG
            into_IN consideration_NN all_DT 10_CD mm_NN thick_JJ CT_NNP sections_NNS between_IN
            the_DT apex_NN and_CC the_DT lung_NN base_NN ._. The_DT distribution_NN of_IN gas_NN and_CC
            lung_NN tissue_NN along_IN the_DT anteroposterior_NN axis_NNS was_VBD
            determined_VBN on_IN five_CD contiguous_JJ 10_CD mm_NN thick_JJ CT_NNP sections_NNS
            located_VBN around_IN the_DT tracheal_NN carina_NN (_( one_CD located_VBN at_IN the_DT
            carina_NN level_NN ,_, and_CC two_CD above_IN and_CC two_CD below_IN the_DT carina_NN
            level_NN )_) by_IN taking_VBG into_IN consideration_NN 10_CD contiguous_JJ
            compartments_NNS of_IN similar_JJ height_NN between_IN the_DT sternum_NN and_CC
            the_DT vertebrae_NN [_NN 17_CD ]_NN ._.
          
          
            Maximal_NNP artifactual_NN increase_NN in_IN lung_NN
            tissue_NN
            In_IN each_DT patient_NN ,_, blood_NN density_NN was_VBD measured_VBN in_IN the_DT
            pulmonary_JJ artery_NN before_IN and_CC after_IN injection_NN of_IN contrast_NN
            material_NN in_IN order_NN to_TO determine_VB the_DT concentration_NN of_IN
            contrast_NN material_NN present_JJ in_IN the_DT pulmonary_JJ circulation_NN
            30_CD s_VBZ and_CC 15_CD min_NN after_IN injection_NN ._.
            The_DT maximal_NN artifactual_NN increase_NN in_IN lung_NN tissue_NN was_VBD
            calculated_VBN as_IN follows_VBZ ._. First_LS ,_, it_PRP was_VBD hypothesized_VBN that_IN
            the_DT 80_CD ml_NN contrast_NN material_NN had_VBD penetrated_VBN into_IN the_DT
            alveolar-interstitial_JJ compartment_NN and_CC had_VBD created_VBN a_DT
            gas-contrast_JJ material_NN interface_NN ._. It_PRP was_VBD assumed_VBN that_IN
            the_DT alveolar-interstitial_JJ contrast_NN material_NN
            concentration_NN was_VBD equal_JJ to_TO the_DT concentration_NN measured_VBN
            within_IN pulmonary_JJ arteries_NNS ,_, a_DT positive_JJ concentration_NN
            gradient_NN between_IN extravascular_NN and_CC vasular_NN spaces_NNS being_VBG
            very_RB unlikely_JJ ._. The_DT new_JJ CT_NNP number_NN of_IN the_DT lung_NN parenchyma_NN
            (_( CT_NNP 
            new_JJ )_) was_VBD then_RB calculated_VBN as_IN
            follows_VBZ :_:
            
            Where_WRB CT_NNP 
            control_NN =_SYM mean_VB CT_NNP number_NN of_IN the_DT lung_NN
            parenchyma_NN before_IN injection_NN ,_, volume_NN 
            tot_NN control_NN =_SYM total_JJ lung_NN volume_NN
            before_IN injection_NN ,_, and_CC CT_NNP 
            blood_NN inj_NN =_SYM CT_NNP number_NN of_IN the_DT
            pulmonary_JJ artery_NN following_VBG injection_NN ._. The_DT apparent_JJ
            volume_NN of_IN lung_NN tissue_NN following_VBG injection_NN (_( V_NNP 
            tissue_NN 1_LS )_) would_MD have_VB been_VBN calculated_VBN
            as_IN follows_VBZ :_:
            V_NNP 
            tissue_NN 1_CD =_SYM (_( [_NN 1_CD +_NN CT_NNP 
            new_JJ ]_NN /_NN 1000_CD )_) ×_NN volume_NN 
            tot_NN inj_NN (_( 6_CD )_)
            Where_WRB volume_NN 
            tot_NN inj_NN =_SYM total_JJ lung_NN volume_NN
            following_VBG injection_NN ._. If_IN the_DT 80_CD ml_NN contrast_NN material_NN had_VBD
            been_VBN replaced_VBN by_IN 80_CD ml_NN plasma_NN ,_, then_RB the_DT new_JJ CT_NNP number_NN
            (_( CT_NNP 
            80_CD )_) and_CC the_DT calculated_VBN volume_NN of_IN
            lung_NN tissue_NN (_( V_NNP 
            tissue_NN 2_LS )_) would_MD have_VB been_VBN :_:
            
            V_NNP 
            tissue_NN 2_CD =_SYM (_( [_NN 1_CD +_NN CT_NNP 
            80_CD ]_NN /_NN 1000_CD )_) ×_NN volume_NN 
            tot_NN inj_NN 
            Where_WRB CT_NNP 
            blood_NN control_NN =_SYM CT_NNP number_NN of_IN the_DT
            pulmonary_JJ artery_NN before_IN injection_NN ._. The_DT maximal_NN
            artifactual_NN increase_NN in_IN lung_NN tissue_NN following_VBG the_DT
            injection_NN of_IN contrast_NN material_NN was_VBD then_RB calculated_VBN as_IN V_NNP
            
            tissue_NN 1_CD -_: V_NNP 
            tissue_NN 2_CD ,_, and_CC the_DT minimal_JJ actual_JJ
            increase_NN in_IN lung_NN tissue_NN as_IN the_DT apparent_JJ increase_NN in_IN
            lung_NN tissue_NN minus_CC the_DT maximal_NN artifactual_NN increase_NN in_IN
            lung_NN tissue_NN ._.
          
        
        
          Preparation_NNP of_IN the_DT human_JJ lung_NN phantom_JJ
          The_DT error_NN resulting_VBG from_IN the_DT presence_NN of_IN contrast_NN
          material_NN in_IN the_DT determination_NN of_IN gas_NN and_CC lung_NN tissue_NN
          volumes_NNS was_VBD assessed_VBN on_IN a_DT lung_NN phantom_JJ that_WDT was_VBD prepared_VBN
          according_VBG to_TO a_DT technique_NN proposed_VBN by_IN Markarian_NNP and_CC Dailey_NNP
          in_IN 1975_CD [_NN 18_CD ,_, 19_CD ]_NN ._. This_DT simple_JJ and_CC easily_RB implemented_VBN
          method_NN is_VBZ aimed_VBN at_IN producing_VBG a_DT lung_NN specimen_NN that_WDT can_MD be_VB
          stored_VBN for_IN over_IN 10_CD years_NNS without_IN damage_NN [_NN 20_CD ]_NN and_CC is_VBZ
          suitable_JJ for_IN histopathology_NN ,_, radiography_NN and_CC CT_NNP
          examinations_NNS ._.
          In_IN 1993_CD ,_, a_DT postmortem_NN left_VBD pneumonectomy_NN was_VBD performed_VBN
          in_IN a_DT 65_CD -_: year-old_JJ man_NN who_WP died_VBD from_IN acute_JJ respiratory_JJ
          distress_NN syndrome_NN complicating_VBG postoperative_JJ
          bronchopneumonia_NN 5_CD days_NNS after_IN surgical_JJ resection_NN of_IN a_DT
          thoracoabdominal_NN aortic_JJ aneurysm_NN ._. The_DT pneumonectomy_NN was_VBD
          performed_VBN according_VBG to_TO the_DT French_JJ legislation_NN (_( law_NN no_DT
          781181_CD ,_, December_NNP 22_CD ,_, 1976_CD ,_, followed_VBN by_IN the_DT statutory_JJ
          order_NN no_DT 78501_CD of_IN March_NNP 31_CD ,_, 1978_CD and_CC the_DT implementation_NN
          order_NN of_IN April_NNP 3_CD ,_, 1978_CD )_) and_CC after_IN obtaining_VBG informed_VBN
          consent_NN from_IN the_DT patient_NN 's_POS relatives_NNS ._. A_DT thoracotomy_NN was_VBD
          performed_VBN in_IN the_DT fifth_RB left_JJ intercostal_NN space_NN at_IN the_DT
          bedside_NN under_IN surgical_JJ conditions_NNS within_IN 20_CD min_NN after_IN
          death_NN ._. After_IN cessation_NN of_IN mechanical_JJ ventilation_NN ,_, both_DT
          lungs_NNS were_VBD then_RB removed_VBN from_IN the_DT thorax_NN ,_, with_IN the_DT trachea_NN
          being_VBG sectioned_JJ immediately_RB beneath_IN the_DT larynx_NN ._. After_IN
          dissection_NN (_( carefully_RB avoiding_VBG lung_NN laceration_NN )_) ,_, both_DT
          lungs_NNS were_VBD separated_VBN by_IN a_DT tracheal_NN section_NN at_IN the_DT carina_NN
          level_NN ,_, leaving_VBG a_DT long_JJ portion_NN of_IN the_DT left_NN main_JJ stem_NN
          bronchus_JJ ;_: the_DT pulmonary_JJ vessels_NNS were_VBD tied_VBN with_IN strings_NNS ;_:
          and_CC the_DT left_NN main_JJ stem_NN bronchus_JJ was_VBD cannulated_JJ with_IN an_DT
          endotracheal_NN tube_NN no_DT 7_CD ._. 5_CD ._. The_DT left_VBN lung_NN was_VBD then_RB inflated_VBN
          via_IN the_DT endotracheal_NN tube_NN by_IN a_DT fixative_JJ composed_VBN of_IN
          polyethylene_NN glycol_NN 400_CD (_( 25_CD %_NN )_) ,_, ethyl_NN alcohol_NN 95_CD %_NN (_( 10_CD %_NN )_) ,_,
          formaldehyde_NN 37_CD %_NN (_( 10_CD %_NN )_) and_CC water_NN (_( 55_CD %_NN )_) ._. The_DT fixative_JJ was_VBD
          instilled_JJ by_IN gravity_NN at_IN a_DT pressure_NN of_IN 30_CD cmH_NN 
          2_CD O_NNP until_IN the_DT lung_NN surface_NN was_VBD firmly_RB
          distended_JJ and_CC small_JJ amounts_NNS of_IN fixative_JJ were_VBD weeping_VBG
          through_IN the_DT pleural_NN surface_NN ._. The_DT endotracheal_NN tube_NN was_VBD
          clamped_VBN in_IN order_NN to_TO prevent_VB loss_NN of_IN fluid_JJ ,_, and_CC the_DT lung_NN
          specimen_NN was_VBD floated_VBN in_IN a_DT container_NN filled_VBN with_IN the_DT same_JJ
          fixative_JJ for_IN 7_CD days_NNS ._.
          The_DT lung_NN was_VBD then_RB suspended_VBN from_IN a_DT ring_NN stand_NN over_IN a_DT
          drip_NN basin_NN and_CC the_DT endotracheal_NN tube_NN was_VBD connected_VBN to_TO a_DT
          source_NN of_IN air_NN equipped_VBN with_IN a_DT continuous_JJ positive_JJ airway_NN
          pressure_NN system_NN set_VBN at_IN a_DT pressure_NN of_IN 30_CD cmH_NN 
          2_CD O_NNP ._. The_DT air_NN pressure_NN causing_VBG the_DT
          fixative_JJ to_TO weep_NN from_IN the_DT pleural_NN surface_NN was_VBD maintained_VBN
          over_IN 3_CD days_NNS ,_, and_CC a_DT dry_JJ left_JJ lung_NN with_IN spongy_NN texture_NN was_VBD
          obtained_VBN ._. The_DT lung_NN was_VBD stored_VBN in_IN a_DT hermetically_RB sealed_VBN
          bag_NN between_IN 1993_CD and_CC 1999_CD without_IN detectable_JJ
          deterioration_NN ._.
        
        
          Effects_NNPS of_IN contrast_NN material_NN on_IN computed_JJ tomography_NN
          determination_NN of_IN lung_NN volumes_NNS
          The_DT effect_NN of_IN contrast_NN material_NN on_IN CT_NNP determination_NN of_IN
          gas_NN and_CC lung_NN tissue_NN volumes_NNS was_VBD assessed_VBN according_VBG to_TO a_DT
          technique_NN recently_RB described_VBD [_NN 15_CD ]_NN ._.
          In_IN a_DT first_JJ step_NN ,_, the_DT contrast_NN material_NN was_VBD diluted_VBN
          with_IN water_NN to_TO obtain_VB solutions_NNS of_IN increasing_VBG
          concentrations_NNS :_: 0_CD %_NN ,_, 0_CD ._. 1_CD %_NN ,_, 0_CD ._. 5_CD %_NN ,_, 1_CD %_NN ,_, 1_CD ._. 5_CD %_NN ,_, 2_CD %_NN and_CC 5_CD %_NN ._. The_DT
          mean_NN CT_NNP attenuation_NN corresponding_JJ to_TO each_DT concentration_NN
          of_IN contrast_NN material_NN was_VBD measured_VBN by_IN scanning_VBG one_CD
          reservoir_NN filled_VBN with_IN water_NN and_CC six_CD reservoirs_NNS filled_VBN
          with_IN the_DT solutions_NNS of_IN increasing_VBG concentrations_NNS ._. The_DT CT_NNP
          attenuation_NN of_IN pure_JJ contrast_NN material_NN was_VBD 3918_CD HU_NNP ._. As_IN
          shown_VBN in_IN Fig_NNP ._. 1_LS ,_, CT_NNP attenuation_NN increased_VBN linearly_RB with_IN
          the_DT concentration_NN of_IN contrast_NN material_NN in_IN the_DT
          solution_NN ._.
          In_IN a_DT second_JJ step_NN ,_, assessment_NN of_IN the_DT artifactual_NN
          changes_NNS in_IN gas_NN and_CC tissue_NN volume_NN in_IN the_DT presence_NN of_IN
          contrast_NN material_NN was_VBD performed_VBN on_IN the_DT lung_NN phantom_JJ ._. The_DT
          volumes_NNS of_IN the_DT different_JJ aliquots_NNS instilled_JJ in_IN the_DT
          phantom_JJ were_VBD compared_VBN with_IN the_DT volumes_NNS computed_JJ using_VBG
          Lungview_NNP ®_NN on_IN the_DT corresponding_JJ CT_NNP scans_VBZ ._. Equation_NNP 4_CD above_IN
          (_( which_WDT does_VBZ not_RB take_VB into_IN consideration_NN the_DT presence_NN of_IN
          contrast_NN material_NN )_) was_VBD used_VBN for_IN this_DT calculation_NN ._. Eight_CD
          CT_NNP scans_NNS of_IN the_DT human_JJ lung_NN phantom_JJ were_VBD performed_VBN
          following_VBG successive_JJ bronchial_NN instillations_NNS of_IN water_NN or_CC
          solution_NN containing_VBG 5_CD %_NN iobitridol_NN ._. The_DT phantom_JJ was_VBD first_RB
          filled_VBN with_IN three_CD aliquots_NNS of_IN water_NN (_( 50_CD ,_, 100_CD and_CC 150_CD ml_NN )_)
          administered_VBN into_IN the_DT left_NN mainstem_NN bronchus_JJ ._. After_IN each_DT
          aliquot_NN ,_, the_DT phantom_JJ was_VBD weighed_VBN using_VBG an_DT electronic_JJ
          scale_NN (_( Teraillon_NNP BE_VB 201_CD ,_, Paris_NNP ,_, France_NNP )_) ._. The_DT phantom_JJ was_VBD
          then_RB dried_VBN with_IN a_DT hair_NN drier_NN until_IN its_PRP$ weight_NN returned_VBD to_TO
          the_DT initial_JJ dry_JJ weight_NN ._. One_CD week_NN later_RB ,_, the_DT phantom_JJ was_VBD
          filled_VBN with_IN three_CD aliquots_NNS of_IN a_DT solution_NN containing_VBG 5_CD %_NN of_IN
          iobitridol_NN and_CC weighed_VBD after_IN each_DT aliquot_NN ._.
          The_DT volume_NN of_IN each_DT aliquot_NN of_IN water_NN was_VBD equivalent_JJ to_TO
          its_PRP$ weight_NN (_( physical_JJ density_NN =_SYM 1_CD mg_NN /_NN ml_NN )_) ._. The_DT volume_NN of_IN
          each_DT aliquot_NN (_( W_NNP 
          aliq_NN )_) containing_VBG 5_CD %_NN contrast_NN material_NN
          was_VBD lower_JJR than_IN its_PRP$ weight_NN (_( physical_JJ density_NN =_SYM 1_CD ._. 2_CD g_SYM /_NN ml_NN )_) ._.
          As_IN a_DT consequence_NN ,_, the_DT volume_NN of_IN the_DT aliquot_NN (_( V_NNP 
          aliq_NN )_) was_VBD calculated_VBN as_IN V_NNP 
          aliq_NN =_SYM 0_CD ._. 943_CD ._. W_NNP 
          aliq_NN ._. The_DT volume_NN of_IN each_DT aliquot_NN
          measured_VBN from_IN its_PRP$ weight_NN was_VBD then_RB compared_VBN with_IN the_DT
          volume_NN of_IN the_DT aliquot_NN calculated_VBD using_VBG Lungview_NNP ®_NN ._.
        
        
          Statistical_NNP analysis_NN
          Results_NNS are_VBP expressed_VBN as_IN mean_NN ±_NN SD_NNP ._. Lung_NNP volumes_NNS
          before_IN and_CC after_IN injection_NN of_IN contrast_NN material_NN were_VBD
          compared_VBN using_VBG a_DT Wilcoxon_NNP test_NN ._. The_DT measured_VBN and_CC Lungview_NNP
          ®_NN -_: derived_VBN volumes_NNS of_IN aliquots_NNS were_VBD compared_VBN by_IN linear_JJ
          regression_NN analysis_NN and_CC using_VBG the_DT Bland-_NNP Altman_NNP method_NN [_NN
          21_CD ]_NN ._. Statistical_NNP analysis_NN was_VBD performed_VBN using_VBG Statview_NNP
          5_CD ._. 0_CD (_( SAS_NNP Institute_NNP Inc_NNP ._. ,_, Cary_NNP ,_, NC_NNP ,_, USA_NNP )_) ,_, and_CC 
          P_NN <_NN 0_CD ._. 05_CD was_VBD considered_VBN
          statistically_RB significant_JJ ._.
        
      
      
        Results_NNS
        
          Patients_NNS
          The_DT clinical_JJ and_CC respiratory_JJ characteristics_NNS of_IN the_DT 14_CD
          patients_NNS are_VBP summarized_VBD in_IN Table_NNP 1_CD ._. No_DT statistically_RB
          significant_JJ differences_NNS were_VBD found_VBN between_IN the_DT two_CD
          groups_NNS ._. Patients_NNS were_VBD admitted_VBN for_IN ALI_NNP complicating_VBG major_JJ
          vascular_NN surgery_NN (_( 
          n_NN =_SYM 7_CD )_) ,_, oesophageal_NN surgery_NN (_( 
          n_NN =_SYM 1_LS )_) and_CC multiple_JJ trauma_NN (_( 
          n_NN =_SYM 6_CD )_) ._. All_DT patients_NNS except_IN one_CD
          were_VBD receiving_VBG norepinephrine_NN (_( noradrenaline_NN )_) for_IN septic_JJ
          shock_NN ._. Eight_CD patients_NNS met_VBD criteria_NNS for_IN acute_JJ respiratory_JJ
          distress_NN syndrome_NN [_NN 22_CD ]_NN ._.
        
        
          Effects_NNPS of_IN injection_NN of_IN contrast_NN material_NN on_IN
          volumes_NNS of_IN gas_NN and_CC lung_NN tissue_NN
          Table_NNP 2_CD shows_VBZ the_DT CT_NNP number_NN of_IN pulmonary_JJ arteries_NNS
          before_IN and_CC after_IN injection_NN of_IN contrast_NN material_NN ._. The_DT
          pulmonary_JJ arterial_NN concentration_NN of_IN contrast_NN material_NN
          ranged_VBD between_IN 0_CD ._. 3_CD %_NN and_CC 2_CD %_NN at_IN 30_CD s_VBZ after_IN the_DT injection_NN ,_,
          and_CC between_IN 0_CD %_NN and_CC 0_CD ._. 07_CD %_NN at_IN 15_CD min_NN after_IN the_DT injection_NN ._.
          Figs_NNP ._. 2_LS shows_VBZ 3_CD representative_NN CT_NNP sections_NNS acquired_VBN in_IN one_CD
          patient_NN at_IN baseline_NN ,_, 30_CD s_VBZ and_CC 15_CD min_NN following_VBG injection_NN
          of_IN contrast_NN material_NN ._. Pulmonary_NNP vessels_NNS were_VBD opacified_JJ by_IN
          contrast_NN material_NN only_RB on_IN the_DT CT_NNP sections_NNS taken_VBN 30_CD s_VBZ
          after_IN injection_NN ,_, whereas_IN lung_NN parenchyma_NN was_VBD opacified_JJ on_IN
          CT_NNP sections_NNS taken_VBN 30_CD s_VBZ and_CC 15_CD min_NN after_IN injection_NN ._. The_DT
          corresponding_JJ apparent_JJ volumes_NNS of_IN lung_NN tissue_NN were_VBD 1445_CD
          ml_NN (_( baseline_NN )_) ,_, 1555_CD ml_NN (_( 30_CD s_VBZ )_) and_CC 1553_CD ml_NN (_( 15_CD min_NN )_) ._.
          As_IN shown_VBN in_IN Table_NNP 3_CD ,_, injection_NN of_IN contrast_NN material_NN
          increased_VBD the_DT apparent_JJ volume_NN of_IN lung_NN tissue_NN by_IN 83_CD ±_NN 57_CD
          ml_NN in_IN group_NN 1_CD (_( 
          P_NN =_SYM 0_CD ._. 02_CD )_) and_CC 102_CD ±_NN 80_CD ml_NN in_IN group_NN
          2_CD (_( 
          P_NN =_SYM 0_CD ._. 01_CD )_) ,_, whereas_IN the_DT apparent_JJ
          volume_NN of_IN gas_NN decreased_VBN by_IN 86_CD ±_NN 102_CD ml_NN in_IN group_NN 1_CD (_( 
          P_NN =_SYM 0_CD ._. 03_CD )_) and_CC 90_CD ±_NN 48_CD ml_NN in_IN group_NN 2_CD
          (_( 
          P_NN =_SYM 0_CD ._. 02_CD )_) ._. Total_JJ lung_NN volume_NN
          remained_VBD unchanged_JJ in_IN both_DT groups_NNS ._. The_DT changes_NNS in_IN
          apparent_JJ lung_NN tissue_NN volumes_NNS between_IN the_DT two_CD groups_NNS did_VBD
          not_RB reach_VB statistical_JJ significance_NN (_( 
          P_NN =_SYM 0_CD ._. 06_CD )_) ._.
          As_IN shown_VBN in_IN Fig_NNP ._. 3_LS ,_, the_DT individual_JJ increase_NN in_IN lung_NN
          tissue_NN volume_NN was_VBD variable_JJ from_IN one_CD patient_NN to_TO another_DT ,_,
          ranging_VBG from_IN 2_CD %_NN to_TO 20_CD %_NN and_CC with_IN mean_NN changes_NNS of_IN 8_CD ±_NN 6_CD %_NN in_IN
          group_NN 1_CD and_CC 7_CD ±_NN 5_CD %_NN in_IN group_NN 2_CD ._. Thirty_NNP seconds_NNS after_IN the_DT
          injection_NN ,_, the_DT maximal_NN artifactual_NN increase_NN in_IN lung_NN
          tissue_NN represented_VBD 39_CD ±_NN 35_CD %_NN of_IN the_DT apparent_JJ increase_NN in_IN
          lung_NN tissue_NN (_( extremes_NNS 0_CD and_CC 85_CD %_NN )_) ._. Fifteen_CD minutes_NNS after_IN
          the_DT injection_NN ,_, the_DT maximal_NN artifactual_NN increase_NN in_IN lung_NN
          tissue_NN represented_VBD 45_CD ±_NN 43_CD %_NN of_IN the_DT apparent_JJ increase_NN in_IN
          lung_NN tissue_NN (_( extremes_NNS 6_CD and_CC 100_CD %_NN )_) ._.
        
        
          Effects_NNPS of_IN contrast_NN material_NN on_IN computed_JJ tomography_NN
          lung_NN volume_NN determination_NN
          As_IN shown_VBN in_IN Fig_NNP ._. 4_LS ,_, a_DT close_JJ correlation_NN was_VBD found_VBN
          between_IN the_DT measured_VBN volumes_NNS of_IN aliquots_NNS and_CC the_DT volumes_NNS
          of_IN aliquots_NNS calculated_VBD using_VBG Lungview_NNP ®_NN ._. The_DT mean_JJ bias_NN
          and_CC precision_NN were_VBD -_: 0_CD ._. 7_CD and_CC 9_CD ml_NN when_WRB the_DT fixed_VBN lung_NN
          model_NN was_VBD instilled_JJ with_IN water_NN ,_, and_CC -_: 8_CD ._. 8_CD and_CC 3_CD ._. 8_CD ml_NN when_WRB
          a_DT solution_NN containing_VBG 5_CD %_NN of_IN contrast_NN material_NN was_VBD
          instilled_JJ ,_, respectively_RB ._. The_DT presence_NN of_IN contrast_NN
          material_NN in_IN the_DT aliquots_NNS was_VBD associated_VBN with_IN an_DT 8_CD %_NN
          overestimation_NN of_IN the_DT liquid_JJ volume_NN by_IN Lungview_NNP ®_NN ._.
        
      
      
        Discussion_NNP
        The_DT present_JJ study_NN shows_VBZ an_DT increase_NN in_IN the_DT volume_NN of_IN
        lung_NN tissue_NN at_IN 30_CD s_VBZ and_CC at_IN 15_CD min_NN after_IN injection_NN of_IN
        contrast_NN material_NN in_IN patients_NNS with_IN ALI_NNP ._. This_DT finding_VBG
        probably_RB results_VBZ from_IN a_DT true_JJ increase_NN in_IN extravascular_NN lung_NN
        water_NN and_CC from_IN an_DT artifactual_NN increase_NN in_IN lung_NN density_NN
        caused_VBN by_IN the_DT intrapulmonary_JJ diffusion_NN of_IN contrast_NN
        material_NN ._. The_DT former_JJ effect_NN ,_, which_WDT is_VBZ not_RB observed_VBN when_WRB the_DT
        lungs_NNS are_VBP healthy_JJ [_NN 2_CD ]_NN ,_, probably_RB depends_VBZ on_IN alteration_NN in_IN
        the_DT alveolar-capillary_JJ barrier_NN that_WDT promotes_VBZ extravascular_NN
        leakage_NN of_IN contrast_NN material_NN ._.
        The_DT accuracy_NN of_IN Lungview_NNP ®_NN for_IN measuring_VBG lung_NN tissue_NN
        volume_NN was_VBD recently_RB assessed_VBN by_IN instilling_VBG known_VBN volumes_NNS of_IN
        water_NN and_CC albumin_NN into_IN a_DT fixed_VBN spongy_NN textured_JJ human_JJ lung_NN
        phantom_JJ [_NN 15_CD ]_NN ._. In_IN the_DT present_JJ study_NN ,_, using_VBG the_DT same_JJ model_NN ,_,
        we_PRP found_VBD that_IN the_DT administration_NN of_IN solutions_NNS containing_VBG 5_CD %_NN
        of_IN contrast_NN material_NN resulted_VBD in_IN an_DT 8_CD %_NN artifactual_NN
        overestimation_NN of_IN lung_NN tissue_NN volume_NN ._. A_DT 5_CD %_NN concentration_NN
        was_VBD chosen_VBN to_TO mimic_VB clinical_JJ conditions_NNS ;_: as_IN shown_VBN in_IN Fig_NNP ._.
        2_LS ,_, pulmonary_JJ vessels_NNS and_CC lung_NN parenchyma_NN were_VBD opacified_JJ 30_CD
        s_VBZ after_IN injection_NN of_IN contrast_NN material_NN ,_, and_CC CT_NNP attenuations_NNS
        measured_VBN in_IN pulmonary_JJ arteries_NNS corresponded_VBD to_TO low_JJ
        concentrations_NNS of_IN contrast_NN material_NN ranging_VBG between_IN 0_CD ._. 3_CD %_NN
        and_CC 2_CD %_NN ._. In_IN six_CD patients_NNS the_DT apparent_JJ increase_NN in_IN lung_NN
        tissue_NN was_VBD either_CC below_IN or_CC slightly_RB greater_JJR than_IN 8_CD %_NN of_IN the_DT
        preinjection_NN lung_NN tissue_NN volume_NN ,_, and_CC could_MD therefore_RB be_VB
        artifactual_NN ._. However_RB ,_, the_DT concentration_NN of_IN contrast_NN
        material_NN was_VBD less_JJR than_IN 2_CD %_NN in_IN all_DT patients_NNS ,_, and_CC we_PRP
        calculated_VBD the_DT maximal_NN artifactual_NN increase_NN in_IN lung_NN tissue_NN
        that_WDT would_MD have_VB resulted_VBN from_IN a_DT total_JJ leakage_NN of_IN the_DT
        contrast_NN material_NN into_IN the_DT lung_NN parenchyma_NN ._. As_IN shown_VBN in_IN
        Table_NNP 4_CD and_CC Fig_NNP ._. 3_LS ,_, after_IN eliminating_VBG the_DT maximal_NN
        artifactual_NN increase_NN in_IN lung_NN tissue_NN ,_, a_DT true_JJ increase_NN in_IN the_DT
        volume_NN of_IN lung_NN tissue_NN was_VBD observed_VBN in_IN each_DT individual_NN ._. It_PRP
        must_MD be_VB pointed_VBN out_RP that_IN the_DT assumption_NN that_IN 100_CD %_NN of_IN the_DT
        contrast_NN material_NN had_VBD penetrated_VBN into_IN the_DT lung_NN parenchyma_NN
        30_CD s_VBZ after_IN the_DT injection_NN is_VBZ unlikely_JJ to_TO be_VB valid_JJ ._. As_IN a_DT
        consequence_NN ,_, the_DT actual_JJ increase_NN in_IN lung_NN tissue_NN was_VBD in_IN fact_NN
        much_RB greater_JJR ,_, depending_VBG on_IN the_DT amount_NN of_IN contrast_NN material_NN
        that_WDT penetrated_VBN into_IN the_DT lungs_NNS ._. In_IN healthy_JJ volunteers_NNS ,_,
        injection_NN of_IN contrast_NN material_NN did_VBD not_RB produce_VB any_DT
        detectable_JJ modification_NN in_IN the_DT lung_NN tissue_NN volume_NN
        calculated_VBD using_VBG Lungview_NNP ®_NN ,_, probably_RB because_IN the_DT contrast_NN
        material_NN remained_VBD strictly_RB intravascular_NN in_IN the_DT presence_NN of_IN
        an_DT intact_JJ alveolar-capillary_JJ barrier_NN and_CC was_VBD rapidly_RB
        eliminated_VBN in_IN the_DT urine_NN [_NN 2_CD ]_NN ._.
        Fifteen_CD minutes_NNS after_IN injection_NN pulmonary_JJ vessels_NNS were_VBD
        no_DT longer_RB opacified_JJ ,_, and_CC CT_NNP attenuations_NNS measured_VBN in_IN
        pulmonary_JJ arteries_NNS corresponded_VBD to_TO concentrations_NNS of_IN
        contrast_NN material_NN of_IN 0_CD ._. 1_CD %_NN or_CC less_JJR ._. In_IN the_DT patients_NNS with_IN an_DT
        apparent_JJ increase_NN in_IN lung_NN tissue_NN of_IN greater_JJR than_IN 8_CD %_NN of_IN the_DT
        preinjection_NN lung_NN tissue_NN volume_NN ,_, the_DT artifact_NN created_VBN by_IN
        the_DT presence_NN of_IN contrast_NN material_NN within_IN the_DT lung_NN
        parenchyma_NN contributed_VBD far_RB less_JJR than_IN 25_CD %_NN ._. In_IN other_JJ words_NNS ,_, a_DT
        significant_JJ and_CC clinically_RB relevant_JJ increase_NN in_IN lung_NN tissue_NN
        was_VBD observed_VBN 15_CD min_NN after_IN injection_NN of_IN contrast_NN material_NN in_IN
        four_CD patients_NNS ._. This_DT increase_NN in_IN lung_NN tissue_NN volume_NN is_VBZ
        probably_RB due_JJ to_TO an_DT increase_NN in_IN extravascular_NN lung_NN
        water_NN ._.
        The_DT injured_VBN lung_NN is_VBZ characterized_VBN by_IN an_DT excessive_JJ amount_NN
        of_IN extravascular_NN lung_NN water_NN that_IN accumulates_NNS in_IN
        interstitial_NN and_CC alveolar_NN compartments_NNS and_CC by_IN an_DT
        infiltration_NN of_IN lung_NN structures_NNS by_IN inflammatory_JJ cells_NNS ._.
        Excessive_NNP oedema_NN and_CC lung_NN inflammation_NN are_VBP measured_VBN as_IN
        '_POS tissue_NN in_IN excess_JJ '_POS by_IN the_DT CT_NNP method_NN [_NN 4_CD ]_NN ._. In_IN patients_NNS
        ventilated_VBD for_IN ALI_NNP ,_, variations_NNS in_IN lung_NN tissue_NN volumes_NNS and_CC
        aeration_NN have_VBP been_VBN observed_VBN following_VBG changes_NNS of_IN position_NN
        or_CC administration_NN of_IN positive_JJ end-expiratory_JJ pressure_NN [_NN 5_CD ,_,
        23_CD ,_, 24_CD ,_, 25_CD ]_NN ._. In_IN patients_NNS with_IN chronic_JJ renal_JJ failure_NN ,_,
        haemodialysis-induced_JJ decrease_NN in_IN intravascular_NN and_CC
        extravascular_NN water_NN is_VBZ associated_VBN with_IN a_DT decrease_NN in_IN lung_NN
        CT_NNP attenuation_NN [_NN 26_CD ]_NN ._. In_IN the_DT present_JJ study_NN ,_, injection_NN of_IN
        contrast_NN material_NN shifted_VBD the_DT volumic_JJ distribution_NN of_IN CT_NNP
        attenuation_NN toward_IN higher_JJR values_NNS ,_, suggesting_VBG an_DT increase_NN in_IN
        extravascular_NN lung_NN water_NN ._. A_DT number_NN of_IN elements_NNS support_VBP a_DT
        true_JJ increase_NN in_IN the_DT volume_NN of_IN extravascular_NN lung_NN water_NN
        rather_RB than_IN a_DT simple_JJ density_NN artifact_NN resulting_VBG from_IN the_DT
        presence_NN of_IN contrast_NN material_NN in_IN the_DT vascular_NN space_NN ._. First_LS ,_,
        the_DT increase_NN in_IN volume_NN of_IN lung_NN tissue_NN that_WDT was_VBD observed_VBN 30_CD
        s_VBZ after_IN injection_NN of_IN contrast_NN material_NN persisted_VBD 15_CD min_NN
        later_RB ,_, although_IN the_DT concentrations_NNS of_IN contrast_NN material_NN
        decreased_VBD below_IN 0_CD ._. 1_CD %_NN ,_, thereby_RB creating_VBG a_DT negligible_JJ density_NN
        artifact_NN that_WDT is_VBZ unable_JJ to_TO account_VB for_IN the_DT persisting_VBG
        increase_NN in_IN lung_NN tissue_NN ._. Second_JJ ,_, the_DT mean_JJ increase_NN in_IN the_DT
        volume_NN of_IN lung_NN tissue_NN was_VBD 10_CD -_: fold_VB greater_JJR than_IN the_DT expected_VBN
        increase_NN in_IN pulmonary_JJ blood_NN volume_NN resulting_VBG from_IN injection_NN
        of_IN 80_CD ml_NN contrast_NN material_NN ._. Third_NNP ,_, the_DT majority_NN of_IN patients_NNS
        had_VBD an_DT ALI_NNP characterized_VBN by_IN a_DT lobar_NN CT_NNP attenuation_NN pattern_NN
        with_IN a_DT large_JJ predominance_NN of_IN nonaerated_JJ lung_NN tissue_NN ._.
        Accordingly_RB ,_, the_DT increase_NN in_IN lung_NN tissue_NN was_VBD computed_JJ for_IN a_DT
        good_JJ part_NN as_IN the_DT additional_JJ number_NN of_IN voxels_NNS with_IN a_DT CT_NNP
        attenuation_NN greater_JJR than_IN 0_CD ._. Consequently_RB ,_, the_DT increase_NN in_IN
        CT_NNP attenuation_NN resulting_VBG from_IN the_DT intraparenchymal_NN
        diffusion_NN of_IN contrast_NN material_NN could_MD not_RB be_VB the_DT cause_NN of_IN a_DT
        major_JJ artifactual_NN increase_NN in_IN lung_NN tissue_NN in_IN non-aerated_JJ
        lung_NN regions_NNS ._. Indeed_RB ,_, counting_VBG a_DT voxel_NN with_IN a_DT CT_NNP
        attenuation_NN equal_JJ to_TO 0_CD or_CC +_NN 500_CD HU_NNP has_VBZ the_DT same_JJ significance_NN
        as_IN a_DT lung_NN area_NN with_IN a_DT mean_NN CT_NNP attenuation_NN close_RB to_TO 0_CD ._.
        The_DT amplitude_NN of_IN the_DT increase_NN in_IN lung_NN tissue_NN was_VBD
        variable_JJ from_IN one_CD patient_NN to_TO another_DT ,_, depending_VBG on_IN the_DT
        relative_JJ importance_NN of_IN the_DT artifactual_NN increase_NN in_IN lung_NN
        density_NN and_CC the_DT true_JJ increase_NN in_IN extravascular_NN lung_NN water_NN ._.
        In_IN fact_NN ,_, our_PRP$ findings_NNS partly_RB invalidate_NN a_DT statement_NN that_IN we_PRP
        made_VBD in_IN a_DT previous_JJ study_NN [_NN 2_CD ]_NN that_IN the_DT injection_NN of_IN
        contrast_NN material_NN does_VBZ not_RB influence_VB the_DT distribution_NN of_IN CT_NNP
        numbers_NNS in_IN ALI_NNP ;_: this_DT statement_NN is_VBZ true_JJ in_IN healthy_JJ
        volunteers_NNS but_CC it_PRP does_VBZ not_RB apply_VB to_TO patients_NNS with_IN ALI_NNP ._.
        Although_IN we_PRP did_VBD not_RB assess_VB the_DT clinical_JJ relevance_NN of_IN the_DT
        measured_VBN increase_NN in_IN lung_NN tissue_NN ,_, it_PRP appears_VBZ prudent_JJ to_TO
        restrict_VB the_DT indication_NN of_IN CT_NNP scans_VBZ with_IN contrast_NN to_TO
        specific_JJ indications_NNS such_JJ as_IN diagnosis_NN of_IN pulmonary_JJ
        embolism_NN ._. Based_VBN on_IN the_DT potential_NN of_IN contrast_NN material_NN to_TO
        worsen_VB the_DT respiratory_JJ condition_NN of_IN patients_NNS with_IN ALI_NNP ,_, its_PRP$
        administration_NN to_TO assist_VB in_IN differentiating_VBG between_IN lung_NN
        consolidation_NN and_CC pleural_NN effusion_NN does_VBZ not_RB appear_VB
        justified_JJ ._.
      
      
        Key_JJ messages_NNS
        •_NN In_IN patients_NNS with_IN ALI_NNP ,_, administration_NN of_IN contrast_NN

        material_NN induces_VBZ an_DT apparent_JJ increase_NN in_IN lung_NN tissue_NN
        •_NN This_DT apparent_JJ increase_NN in_IN lung_NN tissue_NN results_NNS from_IN a_DT
        true_JJ increase_NN in_IN extravascular_NN lung_NN water_NN and_CC from_IN an_DT
        artifactual_NN increase_NN in_IN lung_NN density_NN resulting_VBG from_IN leakage_NN
        of_IN contrast_NN material_NN into_IN the_DT lung_NN parenchyma_NN
        •_NN The_DT increase_NN in_IN extravascular_NN lung_NN water_NN persists_VBZ 15_CD
        min_NN after_IN injection_NN
        •_NN Because_IN injection_NN of_IN contrast_NN material_NN may_MD worsen_VB lung_NN
        injury_NN ,_, it_PRP appears_VBZ prudent_JJ to_TO limit_VB this_DT procedure_NN to_TO
        specific_JJ indications_NNS in_IN patients_NNS with_IN ALI_NNP undergoing_VBG a_DT
        thoracic_JJ CT_NNP scan_VB
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Abbreviations_NNP
        ALI_NNP =_SYM acute_JJ lung_NN injury_NN ;_: CT_NNP =_SYM computed_JJ tomography_NN ;_: HU_NNP =_SYM
        Hounsfield_NNP units_NNS ._.
      
    
  
